Holly L. Mendonca

680 total citations
14 papers, 588 citations indexed

About

Holly L. Mendonca is a scholar working on Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Holly L. Mendonca has authored 14 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Holly L. Mendonca's work include Cancer, Hypoxia, and Metabolism (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Holly L. Mendonca is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Holly L. Mendonca collaborates with scholars based in United States and United Kingdom. Holly L. Mendonca's co-authors include Keith R. Laderoute, Virginia K. Langmuir, Joy M. Calaoagan, Gary D. Marty, Kristen D. Arkush, Philip W. Hedrick, Andreas Knapp, Philip A. Stork, Amato J. Giaccia and David Woo and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Holly L. Mendonca

14 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holly L. Mendonca United States	10	254	177	105	99	97	14	588
Kohji Nomura Japan	15	329 1.3×	69 0.4×	120 1.1×	31 0.3×	60 0.6×	34	729
Alexandra Koch Germany	19	666 2.6×	184 1.0×	121 1.2×	26 0.3×	76 0.8×	32	974
Jaime Gómez‐Márquez Spain	20	623 2.5×	55 0.3×	103 1.0×	42 0.4×	114 1.2×	49	986
Gregory B. Peters Australia	21	773 3.0×	120 0.7×	89 0.8×	37 0.4×	420 4.3×	33	1.3k
Conghui Yang China	15	161 0.6×	80 0.5×	134 1.3×	68 0.7×	132 1.4×	44	543
Hans-Jörg Warnatz Germany	12	529 2.1×	74 0.4×	101 1.0×	25 0.3×	82 0.8×	15	766
Yvonne Connolly United Kingdom	17	526 2.1×	99 0.6×	26 0.2×	86 0.9×	48 0.5×	28	796
Alton D. Floyd United States	14	181 0.7×	46 0.3×	34 0.3×	31 0.3×	72 0.7×	21	431
Lisa M. Abegglen United States	10	305 1.2×	156 0.9×	39 0.4×	14 0.1×	155 1.6×	20	580
Paula K. Elder United States	15	686 2.7×	85 0.5×	85 0.8×	23 0.2×	160 1.6×	19	894

Countries citing papers authored by Holly L. Mendonca

Since Specialization

Citations

This map shows the geographic impact of Holly L. Mendonca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly L. Mendonca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly L. Mendonca more than expected).

Fields of papers citing papers by Holly L. Mendonca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly L. Mendonca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly L. Mendonca. The network helps show where Holly L. Mendonca may publish in the future.

Co-authorship network of co-authors of Holly L. Mendonca

This figure shows the co-authorship network connecting the top 25 collaborators of Holly L. Mendonca. A scholar is included among the top collaborators of Holly L. Mendonca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly L. Mendonca. Holly L. Mendonca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Arkush, Kristen D., et al.. (2002). Resistance to three pathogens in the endangered winter-run chinook salmon (Oncorhynchus tshawytscha): effects of inbreeding and major histocompatibility complex genotypes. Canadian Journal of Fisheries and Aquatic Sciences. 59(6). 966–975. 155 indexed citations

Laderoute, Keith R., Joy M. Calaoagan, Cindy Gustafson‐Brown, et al.. (2002). The Response of c-Jun/AP-1 to Chronic Hypoxia Is Hypoxia-Inducible Factor 1α Dependent. Molecular and Cellular Biology. 22(8). 2515–2523. 84 indexed citations

Laderoute, Keith R., Joy M. Calaoagan, Andreas Knapp, Holly L. Mendonca, & Randall S. Johnson. (2001). c-jun Cooperates with SV40 T-Antigen to Sustain MMP-2 Expression in Immortalized Cells. Biochemical and Biophysical Research Communications. 284(5). 1134–1139. 11 indexed citations

Mendonca, Holly L., et al.. (2001). Isolation and Characterization of Four Microsatellite Loci in the Tidewater Goby (Eucyclogobius newberryi). Marine Biotechnology. 3(2). 91–95. 6 indexed citations

Laderoute, Keith R., Holly L. Mendonca, Joy M. Calaoagan, et al.. (1999). Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression Is Induced by Low Oxygen Conditions Found in Solid Tumor Microenvironments. Journal of Biological Chemistry. 274(18). 12890–12897. 118 indexed citations

Laderoute, Keith R., Joy M. Calaoagan, Holly L. Mendonca, et al.. (1996). Early responses of SiHa human squamous carcinoma cells to hypoxic signals. International Journal of Oncology. 8(5). 875–82. 5 indexed citations

Langmuir, Virginia K., Keith R. Laderoute, Holly L. Mendonca, et al.. (1996). Fused pyrazine mono-n-oxides as bioreductive drugs. II cytotoxicity in human cells and oncogenicity in a rodent transformation assay. International Journal of Radiation Oncology*Biology*Physics. 34(1). 79–84. 6 indexed citations

Waleh, Nahid, Merrill Knapp, Holly L. Mendonca, et al.. (1995). Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker.. PubMed. 55(24). 6222–6. 68 indexed citations

Langmuir, Virginia K., et al.. (1994). Synergistic interaction between tirapazamine and cyclophosphamide in human breast cancer xenografts.. PubMed. 54(11). 2845–7. 24 indexed citations

10.

Wilder, Richard B., Virginia K. Langmuir, Holly L. Mendonca, Michael L. Goris, & SJ Knox. (1993). Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.. PubMed. 53(13). 3022–7. 35 indexed citations

11.

Langmuir, Virginia K., Holly L. Mendonca, & David Woo. (1992). Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.. PubMed. 52(17). 4728–34. 40 indexed citations

12.

Langmuir, Virginia K., et al.. (1992). Comparisons of the efficacy of 186Re- and 131I-labeled antibody in multicell spheroids. International Journal of Radiation Oncology*Biology*Physics. 24(1). 127–132. 11 indexed citations

13.

Langmuir, Virginia K., et al.. (1992). Comparisons of sectioned micro‐TLD dose measurements with predicted dose from ¹³¹I‐labeled antibody. Medical Physics. 19(5). 1213–1218. 8 indexed citations

14.

Langmuir, Virginia K. & Holly L. Mendonca. (1992). The Combined Use of 131 I-Labeled Antibody and the Hypoxic Cytotoxin SR 4233 in Vitro and in Vivo. Radiation Research. 132(3). 351–351. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact